Saamya Biotech (India) Ltd.
BSE: 532905
₹1.97
₹-0.10
(-4.83%)
As on 13-Aug-2018IST
Market cap
₹5 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-1.5 %
-
ROCE
-2.9 %
-
Industry P/E
45.14
-
EV/EBITDA
-406.2
-
Debt to Equity
0.1
-
Book Value
₹--
-
EPS
₹-0
-
Face value
10
-
Shares outstanding
24,882,500
10 Years Aggregate
CFO
₹-8.17 Cr
EBITDA
₹1.00 Cr
Net Profit
₹-1.04 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Saamya Biotech (India)
| 3.4 | -- | -- | 4.0 | -14.9 | 1.6 | -14.4 |
|
BSE Sensex*
| -13.2 | -5.5 | -6.8 | -10.5 | 5.2 | 7.0 | 10.5 |
|
BSE Healthcare#
| 7.8 | 0.9 | 7.5 | 8.3 | 24.2 | 13.6 | 12.1 |
|
Company
|
2017
|
2016
|
2015
|
2014
|
|---|---|---|---|---|
|
Saamya Biotech (India)
| -54.6 | -50.7 | 277.2 | 61.3 |
|
BSE Sensex
| 27.9 | 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| 0.5 | -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Saamya Biotech (India)
|
2.0 | 4.9 | 0.0 | 0.0 | -- | -- | -- | 0.2 |
| 3,316.2 | 27,112.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 76.1 | 16.4 | |
| 424.3 | 16,226.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 90.5 | 4.1 | |
| 766.4 | 19,006.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.9 | 3.7 | |
| 868.3 | 15,557.5 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11 | 1.7 | |
| 1,737.8 | 19,927.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.4 | |
| 165.3 | 22,020.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,181.4 | 19,496.2 | 1,284.3 | 134.4 | -- | 30.7 | 79 | 15.1 | |
| 449.5 | 18,132.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.3 | 3.7 | |
| 1,892.9 | 30,770.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 144.5 | 6.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Saamya Biotech (India)
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
2002
-
Chairman
--
-
Managing Director
Y Manivardhan Reddy
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Saamya Biotech (India) Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsQ3 Unaudited Financial Results Feb 14, 2019
23-Feb-2019Q2 Unaudited Financial Results November 14, 2018
23-Feb-2019Financial Results For Year Ended 30-03-2018
31-Aug-2018Financial Results For Quarter Ended 31-12-2017
31-Aug-2018Financial Results For Quarter Ended 30-06-2017
31-Aug-2018No News & Announcements are available.
FAQs for Saamya Biotech (India)
What is the current share price of Saamya Biotech (India) Ltd Today?
The share price of Saamya Biotech (India) Ltd is ₹1.97 (BSE) as of 13-Aug-2018 IST. Saamya Biotech (India) Ltd has given a return of -14.88% in the last 3 years.
What is the current PB & PE ratio of Saamya Biotech (India) Ltd?
Since, TTM earnings of Saamya Biotech (India) Ltd is negative, P/E ratio is not available.
The P/B ratio of Saamya Biotech (India) Ltd is 0.17 times as on 13-Aug-2018, a 96 discount to its peers’ median range of 3.90 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2016
|
0.00
|
0.37
|
|
2015
|
0.00
|
0.24
|
|
2014
|
29.76
|
0.10
|
|
2013
|
0.00
|
0.13
|
|
2012
|
29.55
|
0.28
|
What is the 52 Week High and Low of Saamya Biotech (India) Ltd?
The 52-week high and low of Saamya Biotech (India) Ltd are Rs -- and Rs -- as of 09-Jun-2026.
What is the market cap of Saamya Biotech (India) Ltd?
Saamya Biotech (India) Ltd has a market capitalisation of ₹ 5 Cr as on 13-Aug-2018. As per SEBI classification, it is a company.
Should I invest in Saamya Biotech (India) Ltd?
Before investing in Saamya Biotech (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.